|
2009
|
Invention
|
Peptide capable of extending half-life of peptide of interest in plasma. Disclosed is any one pep... |
|
|
Invention
|
Ghrelin and derivative thereof, or therapeutic agent for chronic respiratory tract infections com... |
|
2008
|
Invention
|
Agent for improving motor complications or psychiatric symptoms in parkinson's disease. It is int... |
|
|
Invention
|
Method for producing pteridine compound and method for producing l-biopterin. Disclosed is a meth... |
|
|
Invention
|
Method for constructing mass of myocardial cells and use of the myocardial cell mass. It is inten... |
|
|
Invention
|
Composition for mucosal administration containing agent for accelerating mucosal absorption of pe... |
|
|
Invention
|
C-terminal--amidated recombinant enzyme derivative. Disclosed are: a C-terminal-α-amidated... |
|
|
Invention
|
Peptide having hypotensive activity. It is intended to provide a novel peptide having a physiolog... |
|
|
Invention
|
Cancer remedy containing antibody against peptide encoded by exon-17 of periostin. A medicinal co... |
|
|
Invention
|
Pharmaceutical composition for prevention of peritoneal fibrosis. Disclosed is a medical means fo... |
|
|
Invention
|
Therapeutic agent for diabetic neuropathy. Disclosed is a therapeutic agent for diabetic neuropat... |
|
|
Invention
|
Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same. D... |
|
|
Invention
|
Agent for prevention of cirrhosis/precancerous lesion comprising natriuretic peptide as active in... |
|
|
Invention
|
Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the ... |
|
2007
|
Invention
|
Method for producing hydrazone. Disclosed is a commercially advantageous method for producing a h... |
|
|
Invention
|
Lyophilized preparation. It is provided a lyophilized preparation stably containing (2S)-1-(4-ami... |
|
|
Invention
|
Therapeutic agent for acceleration of spinal nerve repair comprising ghrelin, derivative thereof ... |
|
|
Invention
|
Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivativ... |
|
|
Invention
|
Liquid preparation.
It is provided a liquid preparation stably including (2S)-1-(4-amino-2,3,5-t... |
|
|
Invention
|
Liquid preparation. It is provided a liquid preparation stably including (2S)-I- (4-amino-2, 3, 5... |
|
|
Invention
|
Seven-membered ring compound, production method thereof and pharmaceutical use thereof. Disclosed... |
|
|
Invention
|
Method for differentiation induction of myocardial cell from pluripotent stem cell. The object is... |
|
|
Invention
|
Novel cell culture method and methods of producing and collecting cell masses using the same. It ... |
|
|
Invention
|
Method for purifying cardiac myocyte and presumptive cardiac myocyte derived from stem cell and f... |
|
2006
|
Invention
|
Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-relat... |
|
|
Invention
|
Preparation with improved bioabsorbability of sapropterin hydrochloride. It is intended to provid... |
|
|
Invention
|
Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivativ... |
|
|
Invention
|
Therapeutic agent for skin or skin repair-promoting agent comprising ghrelin, derivative thereof ... |
|
|
Invention
|
Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as activ... |
|
|
Invention
|
Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell... |
|
|
Invention
|
Glycolipid derivative and drug containing the same as active component.
Glycolipid derivatives h... |
|
|
Invention
|
Glycolipid derivative and therapeutic agent comprising the same as active ingredient. A glycolipi... |
|
|
Invention
|
Insulin resistance improver.
A novel dosage regimen of GLP-1 receptor agonists causes little or ... |
|
|
Invention
|
Agent for improvement of insulin resistance. Disclosed is a novel dosage form of a GLP-1 receptor... |
|
|
Invention
|
Method for producing hydrazone derivatives. The present invention provides an industrially advant... |
|
|
Invention
|
Method for producing alpha form crystals of sapropterin hydrochloride. ABSTRACT A method for sele... |
|
|
Invention
|
Method of detecting relative risk for the onset of atopic dermatitis by gene single nucleotide po... |
|
|
Invention
|
Method of relative risk for the onset of atopic dermatitis by gene single nucleotide polymorphism... |
|
|
Invention
|
Promoter of regeneration of pancreatic &bgr; cell, and promoter of insulin production in pancreat... |
|
2005
|
Invention
|
Process for producing carbon-reduced aldose compounds.
The present invention provides a process ... |
|
|
Invention
|
Process for producing carbon-diminished aldose compound. A process by which 5-deoxy-L-arabinose, ... |
|
|
Invention
|
Method for producing l-biopterin. To provide a method for producing L-biopterin on a large indust... |
|
|
Invention
|
7-membered ring compound, process for producing the same, and medicinal use thereof. A 7-membered... |
|
|
Invention
|
Liquid preparation of physiologically active peptide.
An effective liquid preparation achieves h... |
|
|
Invention
|
Process for production of biopterin compound. The present invention provides a transformed cell w... |
|
2004
|
Invention
|
Pharmaceutical compositions for preventing or treating th1-mediated immune diseases.
[Problems] ... |
|
|
Invention
|
Imidazotriazinone derivatives as pde 7 (phosphodiesterase 7) inhibitors. The present invention pr... |
|
2003
|
Invention
|
Remedy for pemphigoid. An agent for treatment of pemphigoid is provided.
For use as an agent for... |
|
|
Invention
|
Medical compositions containing ghrelin.
It is provided a pharmaceutical composition stably cont... |
|
2002
|
Invention
|
Method of controlling cleavage by ompt protease. Methods of using OmpT protease are provided. In ... |
